Copyright Reports & Markets. All rights reserved.

Global Chitosan Hemostatic Material Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Chitosan Hemostatic Material Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Hemostatic Gauze
    • 1.3.3 Hemostatic Powder
    • 1.3.4 Hemostatic Sponge
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Chitosan Hemostatic Material Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Surgery
    • 1.4.3 First Aid
  • 1.5 Global Chitosan Hemostatic Material Market Size & Forecast
    • 1.5.1 Global Chitosan Hemostatic Material Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Chitosan Hemostatic Material Sales Quantity (2020-2031)
    • 1.5.3 Global Chitosan Hemostatic Material Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Anscare
    • 2.1.1 Anscare Details
    • 2.1.2 Anscare Major Business
    • 2.1.3 Anscare Chitosan Hemostatic Material Product and Services
    • 2.1.4 Anscare Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Anscare Recent Developments/Updates
  • 2.2 Tricol Biomedical
    • 2.2.1 Tricol Biomedical Details
    • 2.2.2 Tricol Biomedical Major Business
    • 2.2.3 Tricol Biomedical Chitosan Hemostatic Material Product and Services
    • 2.2.4 Tricol Biomedical Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Tricol Biomedical Recent Developments/Updates
  • 2.3 Advamedica
    • 2.3.1 Advamedica Details
    • 2.3.2 Advamedica Major Business
    • 2.3.3 Advamedica Chitosan Hemostatic Material Product and Services
    • 2.3.4 Advamedica Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Advamedica Recent Developments/Updates
  • 2.4 Hemoflex
    • 2.4.1 Hemoflex Details
    • 2.4.2 Hemoflex Major Business
    • 2.4.3 Hemoflex Chitosan Hemostatic Material Product and Services
    • 2.4.4 Hemoflex Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Hemoflex Recent Developments/Updates
  • 2.5 Mermaid Medical
    • 2.5.1 Mermaid Medical Details
    • 2.5.2 Mermaid Medical Major Business
    • 2.5.3 Mermaid Medical Chitosan Hemostatic Material Product and Services
    • 2.5.4 Mermaid Medical Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Mermaid Medical Recent Developments/Updates
  • 2.6 Hemostasis
    • 2.6.1 Hemostasis Details
    • 2.6.2 Hemostasis Major Business
    • 2.6.3 Hemostasis Chitosan Hemostatic Material Product and Services
    • 2.6.4 Hemostasis Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Hemostasis Recent Developments/Updates
  • 2.7 Medcura
    • 2.7.1 Medcura Details
    • 2.7.2 Medcura Major Business
    • 2.7.3 Medcura Chitosan Hemostatic Material Product and Services
    • 2.7.4 Medcura Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Medcura Recent Developments/Updates
  • 2.8 BioPharm Med
    • 2.8.1 BioPharm Med Details
    • 2.8.2 BioPharm Med Major Business
    • 2.8.3 BioPharm Med Chitosan Hemostatic Material Product and Services
    • 2.8.4 BioPharm Med Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 BioPharm Med Recent Developments/Updates
  • 2.9 MedTrade Products
    • 2.9.1 MedTrade Products Details
    • 2.9.2 MedTrade Products Major Business
    • 2.9.3 MedTrade Products Chitosan Hemostatic Material Product and Services
    • 2.9.4 MedTrade Products Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 MedTrade Products Recent Developments/Updates
  • 2.10 Shijiazhuang Yishengtang Medical Product
    • 2.10.1 Shijiazhuang Yishengtang Medical Product Details
    • 2.10.2 Shijiazhuang Yishengtang Medical Product Major Business
    • 2.10.3 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Product and Services
    • 2.10.4 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Shijiazhuang Yishengtang Medical Product Recent Developments/Updates
  • 2.11 Biotemed
    • 2.11.1 Biotemed Details
    • 2.11.2 Biotemed Major Business
    • 2.11.3 Biotemed Chitosan Hemostatic Material Product and Services
    • 2.11.4 Biotemed Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Biotemed Recent Developments/Updates
  • 2.12 Haiyuan Hairun
    • 2.12.1 Haiyuan Hairun Details
    • 2.12.2 Haiyuan Hairun Major Business
    • 2.12.3 Haiyuan Hairun Chitosan Hemostatic Material Product and Services
    • 2.12.4 Haiyuan Hairun Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Haiyuan Hairun Recent Developments/Updates
  • 2.13 Yancheng Yankang Medical Equipment
    • 2.13.1 Yancheng Yankang Medical Equipment Details
    • 2.13.2 Yancheng Yankang Medical Equipment Major Business
    • 2.13.3 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Product and Services
    • 2.13.4 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Yancheng Yankang Medical Equipment Recent Developments/Updates
  • 2.14 Success Bio-Tech
    • 2.14.1 Success Bio-Tech Details
    • 2.14.2 Success Bio-Tech Major Business
    • 2.14.3 Success Bio-Tech Chitosan Hemostatic Material Product and Services
    • 2.14.4 Success Bio-Tech Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Success Bio-Tech Recent Developments/Updates
  • 2.15 Lanhine Medical
    • 2.15.1 Lanhine Medical Details
    • 2.15.2 Lanhine Medical Major Business
    • 2.15.3 Lanhine Medical Chitosan Hemostatic Material Product and Services
    • 2.15.4 Lanhine Medical Chitosan Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Lanhine Medical Recent Developments/Updates

3 Competitive Environment: Chitosan Hemostatic Material by Manufacturer

  • 3.1 Global Chitosan Hemostatic Material Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Chitosan Hemostatic Material Revenue by Manufacturer (2020-2025)
  • 3.3 Global Chitosan Hemostatic Material Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Chitosan Hemostatic Material by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Chitosan Hemostatic Material Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Chitosan Hemostatic Material Manufacturer Market Share in 2024
  • 3.5 Chitosan Hemostatic Material Market: Overall Company Footprint Analysis
    • 3.5.1 Chitosan Hemostatic Material Market: Region Footprint
    • 3.5.2 Chitosan Hemostatic Material Market: Company Product Type Footprint
    • 3.5.3 Chitosan Hemostatic Material Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Chitosan Hemostatic Material Market Size by Region
    • 4.1.1 Global Chitosan Hemostatic Material Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Chitosan Hemostatic Material Consumption Value by Region (2020-2031)
    • 4.1.3 Global Chitosan Hemostatic Material Average Price by Region (2020-2031)
  • 4.2 North America Chitosan Hemostatic Material Consumption Value (2020-2031)
  • 4.3 Europe Chitosan Hemostatic Material Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Chitosan Hemostatic Material Consumption Value (2020-2031)
  • 4.5 South America Chitosan Hemostatic Material Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Chitosan Hemostatic Material Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Chitosan Hemostatic Material Sales Quantity by Type (2020-2031)
  • 5.2 Global Chitosan Hemostatic Material Consumption Value by Type (2020-2031)
  • 5.3 Global Chitosan Hemostatic Material Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Chitosan Hemostatic Material Sales Quantity by Application (2020-2031)
  • 6.2 Global Chitosan Hemostatic Material Consumption Value by Application (2020-2031)
  • 6.3 Global Chitosan Hemostatic Material Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Chitosan Hemostatic Material Sales Quantity by Type (2020-2031)
  • 7.2 North America Chitosan Hemostatic Material Sales Quantity by Application (2020-2031)
  • 7.3 North America Chitosan Hemostatic Material Market Size by Country
    • 7.3.1 North America Chitosan Hemostatic Material Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Chitosan Hemostatic Material Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Chitosan Hemostatic Material Sales Quantity by Type (2020-2031)
  • 8.2 Europe Chitosan Hemostatic Material Sales Quantity by Application (2020-2031)
  • 8.3 Europe Chitosan Hemostatic Material Market Size by Country
    • 8.3.1 Europe Chitosan Hemostatic Material Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Chitosan Hemostatic Material Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Chitosan Hemostatic Material Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Chitosan Hemostatic Material Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Chitosan Hemostatic Material Market Size by Region
    • 9.3.1 Asia-Pacific Chitosan Hemostatic Material Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Chitosan Hemostatic Material Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Chitosan Hemostatic Material Sales Quantity by Type (2020-2031)
  • 10.2 South America Chitosan Hemostatic Material Sales Quantity by Application (2020-2031)
  • 10.3 South America Chitosan Hemostatic Material Market Size by Country
    • 10.3.1 South America Chitosan Hemostatic Material Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Chitosan Hemostatic Material Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Chitosan Hemostatic Material Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Chitosan Hemostatic Material Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Chitosan Hemostatic Material Market Size by Country
    • 11.3.1 Middle East & Africa Chitosan Hemostatic Material Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Chitosan Hemostatic Material Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Chitosan Hemostatic Material Market Drivers
  • 12.2 Chitosan Hemostatic Material Market Restraints
  • 12.3 Chitosan Hemostatic Material Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Chitosan Hemostatic Material and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Chitosan Hemostatic Material
  • 13.3 Chitosan Hemostatic Material Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Chitosan Hemostatic Material Typical Distributors
  • 14.3 Chitosan Hemostatic Material Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Chitosan Hemostatic Material market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Chitosan hemostatic materials are a type of biomedical materials based on natural chitosan, which are mainly used to accelerate hemostasis and promote wound healing. Chitosan is a natural polysaccharide extracted from the shells of crustaceans, which has good biocompatibility, antibacterial and degradability. Its hemostatic mechanism includes promoting platelet aggregation, accelerating blood clot formation and constricting blood vessels. Chitosan hemostatic materials are widely used in surgical operations, trauma emergency treatment and the treatment of chronic trauma, and have multiple functions of rapid hemostasis, reducing infection and promoting tissue repair.
    This report is a detailed and comprehensive analysis for global Chitosan Hemostatic Material market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Chitosan Hemostatic Material market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
    Global Chitosan Hemostatic Material market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
    Global Chitosan Hemostatic Material market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
    Global Chitosan Hemostatic Material market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Chitosan Hemostatic Material
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Chitosan Hemostatic Material market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anscare, Tricol Biomedical, Advamedica, Hemoflex, Mermaid Medical, Hemostasis, Medcura, BioPharm Med, MedTrade Products, Shijiazhuang Yishengtang Medical Product, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Chitosan Hemostatic Material market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hemostatic Gauze
    Hemostatic Powder
    Hemostatic Sponge
    Others
    Market segment by Application
    Surgery
    First Aid
    Major players covered
    Anscare
    Tricol Biomedical
    Advamedica
    Hemoflex
    Mermaid Medical
    Hemostasis
    Medcura
    BioPharm Med
    MedTrade Products
    Shijiazhuang Yishengtang Medical Product
    Biotemed
    Haiyuan Hairun
    Yancheng Yankang Medical Equipment
    Success Bio-Tech
    Lanhine Medical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Chitosan Hemostatic Material product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Chitosan Hemostatic Material, with price, sales quantity, revenue, and global market share of Chitosan Hemostatic Material from 2020 to 2025.
    Chapter 3, the Chitosan Hemostatic Material competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Chitosan Hemostatic Material breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Chitosan Hemostatic Material market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Chitosan Hemostatic Material.
    Chapter 14 and 15, to describe Chitosan Hemostatic Material sales channel, distributors, customers, research findings and conclusion.

    Buy now